Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis.
about
Anti-cytokine and anti-endotoxin therapies for meningococcal diseaseAnti-cytokine and anti-endotoxin therapies for meningococcal diseaseProtective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, propertiesInfectious purpura fulminans: diagnosis and treatment.Potential applications of N-terminal recombinant fragments of bactericidal/permeability-increasing protein in liver surgery.A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blooPeptide antibiotics.Update on meningococcal disease with emphasis on pathogenesis and clinical managementHuman antimicrobial proteins in ear wax.Cationic antimicrobial peptides: towards clinical applications.Antimicrobial peptides: properties and applicability.The importance of the gastrointestinal system in the pathogenesis of heart failure.New therapies and vaccines for meningococcal disease.Therapeutic potential of the bactericidal/permeability-increasing protein.Novel therapies for sepsis: antiendotoxin therapies.Recent developments in the treatment of sepsis.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Serum eosinophilic cationic protein may predict clinical course of wheezing in young childrenReduction in case fatality rate from meningococcal disease associated with improved healthcare deliveryManagement of septic shock in childhood.Events at the host-microbial interface of the gastrointestinal tract. I. Adaptation to a microbial world: role of epithelial bactericidal/permeability-increasing protein.Structural and functional features of a developmentally regulated lipopolysaccharide-binding protein.Endogenous pulmonary antibiotics.The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin.Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide.Bactericidal/permeability-increasing protein prevents mucosal damage in an experimental rat model of chronic otitis media with effusion.Activation of extracellular signal-related protein kinases 1 and 2 of the mitogen-activated protein kinase family by lipopolysaccharide requires plasma in neutrophils from adults and newborns.Interaction of Neisseria meningitidis with human dendritic cells.Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.Lipopolysaccharide-binding protein- and CD14-dependent activation of mitogen-activated protein kinase p38 by lipopolysaccharide in human neutrophils is associated with priming of respiratory burst.Arginine-rich cationic polypeptides amplify lipopolysaccharide-induced monocyte activationE5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharideFunctional and biochemical characterization of epithelial bactericidal/permeability-increasing protein.Extracellular release of bactericidal/permeability-increasing protein in newborn infants.Antiendotoxin activity of antimicrobial peptides and glycopeptides.Meningococcal disease: hope on the horizon.
P2860
Q24186999-C6350C23-6500-45FD-9C4A-62D953BA4A4AQ24234359-A38A9CD5-F604-4E2E-9D9A-641067A9FE6FQ24530088-B4C03B4E-0B8C-4FCD-A331-2E62C21BF0E0Q33537329-6AA77B07-7FA7-4F88-A6DB-2F65F007074BQ33539885-4F0D0D6F-6F90-487F-B60B-D33C7917A9ADQ33593645-8A488947-B2C7-46CD-95B6-499A1A2A8AF4Q33599033-D474A64C-77DA-4D22-9F1D-BECC7B307BAFQ33647178-0859CF25-4016-48A4-847A-D203E1C77265Q33812435-4F2DBC92-7B51-4D67-BCDC-C835D2D594F0Q34025657-5ACA2C45-84D0-476D-96EE-51239F6ECA82Q34074985-ED4222D3-A8F0-454E-BEEE-448232C2E29BQ34280947-016777CE-BB13-420F-8F88-5A79F9C40112Q34429097-32D413E3-04B4-4154-A1FD-1B7F7EE00693Q34481640-50C6C4FB-6B0D-401B-B924-16D081F32D4CQ34519111-8FAD28D3-5615-420F-9D55-0FFE66426119Q35011910-D61EB214-6D08-4305-ACDA-7B62D9B64022Q35056046-A6EB9A71-A87B-4074-B60A-A6F06122AB64Q35176262-B222DC30-C709-41F6-AF95-AA947A907487Q35259353-108EBD7F-53D6-431B-9F94-C7CF08CD9776Q35271447-A84AADA1-9B47-453E-A523-867DA3408035Q35828884-5A87329D-96C7-4F52-B84C-9C47194CAD3DQ36069861-37A96C14-118F-4B1F-ACCB-21844B9A8A9DQ36205838-9A322EE4-078B-4FF2-9C10-B1077E19085DQ36487901-F2D9B182-54B1-4690-8FCB-CC94B1CEEDA2Q36902238-C8FDB602-BFB7-443A-90B1-BC698CE8F76CQ37367885-D19C1B32-0B11-4A2A-828E-BF71BF062B12Q37941452-AE2DC6AB-8D1F-43B8-979C-3D4F682A57F5Q39476770-460B037E-051E-43F7-80F4-5A49DD5074E3Q39512909-B5B40E90-9AB5-4039-9737-90EAF9E312DAQ39515770-223FA703-505D-4D73-881A-336F60EBB1B5Q39519915-4F9D3525-C3DB-4807-9FE3-9F585C5E367FQ39529533-7F38ED53-F208-477B-814B-ECA8F2858F3DQ39537763-248CA429-6FA6-437E-9A3E-416B58878718Q39655830-820F3414-CDED-43B7-8290-CA3AFD8AB6AEQ39672321-97F3D3E9-C771-4943-A853-FBA8519FBB10Q41888869-D4C37F9A-50A1-4438-B136-D5C4AE52703CQ42486334-73824F6E-1BEA-42BA-8965-B5B15DC456CFQ42521778-01A12350-9EF3-44AF-A5C9-6FD1237BD05CQ44471907-DAD50262-6928-4E06-9148-AE2B92E6085AQ47595843-7B8CA7D2-F3D9-4187-9F45-6FAF58DCAB00
P2860
Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@en
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@nl
type
label
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@en
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@nl
prefLabel
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@en
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@nl
P2093
P1433
P1476
Preliminary evaluation of reco ...... h severe meningococcal sepsis.
@en
P2093
B Goldstein
B J Nelson
B P Giroir
E A Kirsch
P J Scannon
S F Carroll
P304
P356
10.1016/S0140-6736(97)06468-4
P407
P577
1997-11-01T00:00:00Z